Abstract
Freeze-drying has become one of the most important processes for the preservation of biological products. This chapter provides protocols for freeze-drying of proteins and discusses the importance of formulation, cycle development, and validation. Specific formulations for stabilization of proteins are presented as well as advice on common problems with freeze-drying of proteins.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Passot S, Fonseca F, Alarcon-Lorca M (2005) Physical characterisation of formulations for the development of two stable freeze-dried proteins during both dried and liquid storage. Eur J Pharm Biopharm 60:335–348
Ma X, Wang W, Bouffard R (2001) Characterization of murine monoclonal antibody to tumor necrosis factor (TNF-MAb) formulation for freeze-drying cycle development. Pharm Res 18:196–202
Nail SL, Her LM, Proffitt CPB (1994) An improved microscope stage for direct observation of freezing and freeze drying. Pharm Res 11:1098–1100
Carpenter JF, Chang BS (1996) Lyophilization of protein pharmaceuticals. In: Avis KE, Wu VL (eds) Biotechnology and biopharmaceutical manufacturing, processing and preservation. Interpharm Press, Buffalo Grove, IL, pp 199–264
Wang W (2000) Lyophilization and development of solid protein pharmaceuticals. Int J Pharm 203:1–60
Chang LL, Pikal MJ (2009) Mechanisms of protein stabilization in the solid state. J Pharm Sci 98:2886–2908
Hua TC (2006) New technology of freeze-drying. Science Press, Beijing
Hua TC, Liu BL, Zhang H (2010) Freeze-drying of pharmaceutical and food products. Woodhead Publishing Limited, Sawston
Lim JY, Kim NA, Lim DG, Kim KH, Choi DH, Jeong SH (2016) Process cycle development of freeze drying for therapeutic proteins with stability evaluation. J Pharm Invest 46:519–536
Lipiäinen T, Peltoniemi M, Sarkhel S, Yrjönen T, Vuorela H, Urtti A, Juppo A (2015) Formulation and stability of cytokine therapeutics. J Pharm Sci 104:307–326
Matejtschuk P (2007) Lyophilization of proteins. In: Day JG, Stacey GN (eds) Cryopreservation and freeze-drying protocols, 2nd edn. Humana, New York, pp 59–72
Searles JA, Carpenter JF, Randolph TW (2001) Annealing to optimize primary drying rate, reduce freeze-induced drying rate heterogeneity and determine the Tg in pharmaceutical lyophilization. J Pharm Sci 90:872–877
Jiang S, Nail SL (1998) Effect of process conditions on recovery of protein activity after freezing and freeze-drying. Eur J Pharm Biopharm 45:245–257
Breen ED, Curley JG, Overcashier DE, Hsu CC, Shire SJ (2001) Effect of moisture on the stability of a lyophilized humanised monoclonal antibody formulation. Pharm Res 18:1345–1353
May JC, Wheeler RM, Etz N, Del Grosso A (1992) Measurement of final container residual moisture in freeze dried biological products. Dev Biol Stand 74:153–164
Kirkwood TBL (1984) Design and analysis of accelerated degradation tests for the stability of biological standards III. Principles of design. J Biol Stand 12:215–224
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Liu, B., Zhou, X. (2021). Freeze-Drying of Proteins. In: Wolkers, W.F., Oldenhof, H. (eds) Cryopreservation and Freeze-Drying Protocols. Methods in Molecular Biology, vol 2180. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-0783-1_37
Download citation
DOI: https://doi.org/10.1007/978-1-0716-0783-1_37
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-0782-4
Online ISBN: 978-1-0716-0783-1
eBook Packages: Springer Protocols